Correspondence 0001104659-23-079971 from Sagimet Biosciences Inc. (SGMT)
Sagimet Biosciences Inc.
Date: July 11, 2023 · CIK: 0001400118 · Accession: 0001104659-23-079971
AI Filing Summary & Sentiment
File numbers found in text: 333-272901
Show Raw Text
CORRESP
1
filename1.htm
VIA EDGAR
July 11, 2023
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Cindy Polynice
Alan Campbell
Angela Connell
Gary Newberry
Re: Sagimet
Biosciences Inc. (the “Registrant”)
Registration Statement on Form S-1 (File No. 333-272901)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and
Regulations under the Securities Act of 1933, as amended, we wish to advise that between July 10, 2023 and the date hereof, approximately
1,821 copies of the Preliminary Prospectus, dated July 10, 2023, were distributed to prospective underwriters, institutional
investors and prospective dealers in connection with the above-captioned Registration Statement, as amended.
We wish to advise you that the participating underwriters
have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange
Act of 1934, as amended.
We hereby join in the request of the Registrant
that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time on July 13,
2023, or as soon thereafter as practicable.
[signature page follows]
Very truly yours,
GOLDMAN SACHS & CO.
LLC
COWEN AND COMPANY, LLC
PIPER SANDLER & CO.
As representatives of the Underwriters
GOLDMAN SACHS & CO.
LLC
By:
/s/ Lyla Bibi
Name: Lyla Bibi
Title: Managing Director
COWEN AND COMPANY, LLC
By:
/s/ Tanya Joseph
Name: Tanya Joseph
Title: Managing Director
PIPER SANDLER & CO.
By:
/s/ Chad Huber
Name: Chad Huber
Title: Managing Director
[Signature
Page to Acceleration Request Letter]